1. Home
  2. VALN vs TKNO Comparison

VALN vs TKNO Comparison

Compare VALN & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$8.52

Market Cap

820.0M

Sector

Health Care

ML Signal

HOLD

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$4.64

Market Cap

236.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VALN
TKNO
Founded
2012
1996
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
820.0M
236.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
VALN
TKNO
Price
$8.52
$4.64
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$15.75
N/A
AVG Volume (30 Days)
20.4K
136.3K
Earning Date
11-20-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$211,089,992.00
$39,801,000.00
Revenue This Year
$5.08
$8.79
Revenue Next Year
$12.53
$10.52
P/E Ratio
N/A
N/A
Revenue Growth
13.48
9.50
52 Week Low
$3.62
$3.94
52 Week High
$12.25
$10.37

Technical Indicators

Market Signals
Indicator
VALN
TKNO
Relative Strength Index (RSI) 37.87 47.47
Support Level $8.62 $4.50
Resistance Level $9.10 $4.94
Average True Range (ATR) 0.30 0.25
MACD -0.02 0.02
Stochastic Oscillator 0.76 43.40

Price Performance

Historical Comparison
VALN
TKNO

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Share on Social Networks: